|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
112 a.a.
|
 |
|
|
|
|
|
|
|
108 a.a.
|
 |
|
|
|
|
|
|
|
79 a.a.
|
 |
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Cytokine/cytokine receptor
|
 |
|
Title:
|
 |
Structural basis for cooperative assembly of the tgf-beta si complex
|
|
Structure:
|
 |
Transforming growth factor beta-3. Chain: a. Synonym: tgf-beta-3. Engineered: yes. Tgf-beta receptor type-2. Chain: b. Fragment: extracellular domain. Synonym: tgf-beta receptor type ii, tgfr-2, tgf-beta type i receptor, transforming growth factor-beta receptor type ii,
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: tgfb3. Expressed in: escherichia coli. Expression_system_taxid: 562. Gene: tgfbr2. Gene: tgfbr1. Expression_system_taxid: 562
|
|
Resolution:
|
 |
|
3.00Å
|
R-factor:
|
0.244
|
R-free:
|
0.297
|
|
|
Authors:
|
 |
J.Groppe,C.Zubieta
|
Key ref:
|
 |
J.Groppe
et al.
(2008).
Cooperative assembly of tgf-Beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding.
Mol Cell,
29,
157-168.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
16-Apr-07
|
Release date:
|
05-Feb-08
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
|
|
P10600
(TGFB3_HUMAN) -
Transforming growth factor beta-3
|
|
|
|
Seq: Struc:
|
 |
 |
 |
412 a.a.
112 a.a.
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains B, C:
E.C.2.7.11.30
- Receptor protein serine/threonine kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP + [receptor-protein] = ADP + [receptor-protein] phosphate
|
 |
 |
 |
 |
 |
ATP
|
+
|
[receptor-protein]
|
=
|
ADP
|
+
|
[receptor-protein] phosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
membrane
|
3 terms
|
 |
|
Biological process
|
cell growth
|
3 terms
|
 |
|
Biochemical function
|
receptor activity
|
9 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Mol Cell
29:157-168
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
Cooperative assembly of tgf-Beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding.
|
|
J.Groppe,
C.S.Hinck,
P.Samavarchi-Tehrani,
C.Zubieta,
J.P.Schuermann,
A.B.Taylor,
P.M.Schwarz,
J.L.Wrana,
A.P.Hinck.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Dimeric ligands of the transforming growth factor-beta (TGF-beta) superfamily
signal across cell membranes in a distinctive manner by assembling
heterotetrameric complexes of structurally related serine/threonine-kinase
receptor pairs. Unlike complexes of the bone morphogenetic protein (BMP) branch
that apparently form due to avidity from membrane localization, TGF-beta
complexes assemble cooperatively through recruitment of the low-affinity (type
I) receptor by the ligand-bound high-affinity (type II) pair. Here we report the
crystal structure of TGF-beta3 in complex with the extracellular domains of both
pairs of receptors, revealing that the type I docks and becomes tethered via
unique extensions at a composite ligand-type II interface. Disrupting the
receptor-receptor interactions conferred by these extensions abolishes assembly
of the signaling complex and signal transduction (Smad activation). Although
structurally similar, BMP and TGF-beta receptors bind in dramatically different
modes, mediating graded and switch-like assembly mechanisms that may have
coevolved with branch-specific groups of cytoplasmic effectors.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 4.
Figure 4. TβRI Binds in a Distinct Mode at a Composite
Interface (A) Superposition of TGF-β3[A] onto BMP-2[A]
(gold) in the BMP-2:BMPRIA binary complex. The surface of BMPRIA
is represented in gray (TGF-β3[B], BMP-2[B] not depicted for
simplicity). (B) Superposition of the BMP binary and TGF-β
ternary complexes. TβRI is rotated vert,
similar 45° around the long axis of the ligand relative to
BMPRIA. TGF-β3[A] and TGF-β3[B] are shown as red and blue
surfaces, respectively (TβRII and BMP-2 not depicted). (C)
TGF-β3[A] and TβRI are separated by a wide solvent-filled
channel. Molecular surfaces are depicted over the ribbons of
TGF-β3[A] and TβRI (yellow-gold). (D) Prehelix extension
of TβRI binds long finger of ligand monomer. Prehelix extension
highlighted in red, and ligand monomers are colored and oriented
as in the figure above (TβRII not depicted). (E) TβRI
Arg58-TβRII Asp118 ion pair at the composite interface. TβRII
is shown as ribbon in green, and ligand monomers and TβRI are
as above. (F) TβRII N-terminal extension tethers TβRI to
the composite TGFβ3-TβRII interface. The seven ordered
residues (Asn19–Pro25) of the N-terminal extension of TβRII
(green) are shown as sticks. TβRI (yellow-gold) is depicted as
sticks and as surface. In total, vert,
similar 916 Å^2 of TβRI surface is buried upon binding by
TβRII.
|
 |
Figure 5.
Figure 5. N-Terminal Tether of TβRII Recruits TβRI into
Ternary Complex (A) Sequence of N-terminal extension of
TβRII. The N-terminal tether (underlined, light green) extends
out from the receptor scaffold (dark green) from Pro25 to Asn19.
The first 18 residues appear to be unstructured. Numbering
(based on the mature N terminus, not the initiator methionine of
the signal peptide) refers to the termini of the receptor
constructs below. (B) Native gel analyses of TβRI
recruitment by binary complexes of TGFβ3 and N-terminally
truncated TβRII variants. BC and TC indicate positions of
binary and ternary complexes, respectively. (C) Native gel
analyses of TβRI recruitment by binary complexes of TGF-β3 and
Δ20 TβRII point variants. (D) SPR analyses of TβRI
recruitment by binary complexes of Δ20 TβRII point variants
and fully truncated (Δ25) TβRII.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Mol Cell
(2008,
29,
157-168)
copyright 2008.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.J.Worthington,
J.E.Klementowicz,
and
M.A.Travis
(2011).
TGFβ: a sleeping giant awoken by integrins.
|
| |
Trends Biochem Sci, 36,
47-54.
|
 |
|
|
|
|
 |
T.Huang,
L.David,
V.Mendoza,
Y.Yang,
M.Villarreal,
K.De,
L.Sun,
X.Fang,
F.López-Casillas,
J.L.Wrana,
and
A.P.Hinck
(2011).
TGF-β signalling is mediated by two autonomously functioning TβRI:TβRII pairs.
|
| |
EMBO J, 30,
1263-1276.
|
 |
|
|
|
|
 |
Y.Glinka,
S.Stoilova,
N.Mohammed,
and
G.J.Prud'homme
(2011).
Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta.
|
| |
Carcinogenesis, 32,
613-621.
|
 |
|
|
|
|
 |
C.L.Shovlin
(2010).
Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment.
|
| |
Blood Rev, 24,
203-219.
|
 |
|
|
|
|
 |
L.Li,
B.P.Orner,
T.Huang,
A.P.Hinck,
and
L.L.Kiessling
(2010).
Peptide ligands that use a novel binding site to target both TGF-β receptors.
|
| |
Mol Biosyst, 6,
2392-2402.
|
 |
|
|
|
|
 |
N.Garamszegi,
S.P.Garamszegi,
P.Samavarchi-Tehrani,
E.Walford,
M.M.Schneiderbauer,
J.L.Wrana,
and
S.P.Scully
(2010).
Extracellular matrix-induced transforming growth factor-beta receptor signaling dynamics.
|
| |
Oncogene, 29,
2368-2380.
|
 |
|
|
|
|
 |
R.L.Rich,
and
D.G.Myszka
(2010).
Grading the commercial optical biosensor literature-Class of 2008: 'The Mighty Binders'.
|
| |
J Mol Recognit, 23,
1.
|
 |
|
|
|
|
 |
U.Ripamonti,
R.M.Klar,
L.F.Renton,
and
C.Ferretti
(2010).
Synergistic induction of bone formation by hOP-1, hTGF-beta3 and inhibition by zoledronate in macroporous coral-derived hydroxyapatites.
|
| |
Biomaterials, 31,
6400-6410.
|
 |
|
|
|
|
 |
W.Zhang,
J.Yuan,
Y.Yang,
L.Xu,
Q.Wang,
W.Zuo,
X.Fang,
and
Y.G.Chen
(2010).
Monomeric type I and type III transforming growth factor-β receptors and their dimerization revealed by single-molecule imaging.
|
| |
Cell Res, 20,
1216-1223.
|
 |
|
|
|
|
 |
A.A.Mourskaia,
Z.Dong,
S.Ng,
M.Banville,
J.C.Zwaagstra,
M.D.O'Connor-McCourt,
and
P.M.Siegel
(2009).
Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone.
|
| |
Oncogene, 28,
1005-1015.
|
 |
|
|
|
|
 |
A.Chaudhury,
and
P.H.Howe
(2009).
The tale of transforming growth factor-beta (TGFbeta) signaling: a soigné enigma.
|
| |
IUBMB Life, 61,
929-939.
|
 |
|
|
|
|
 |
A.Kotzsch,
J.Nickel,
A.Seher,
W.Sebald,
and
T.D.Müller
(2009).
Crystal structure analysis reveals a spring-loaded latch as molecular mechanism for GDF-5-type I receptor specificity.
|
| |
EMBO J, 28,
937-947.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Chen,
Q.Lin,
N.Box,
D.Roop,
S.Ishii,
K.Matsuzaki,
T.Fan,
T.J.Hornyak,
J.A.Reed,
E.Stavnezer,
N.A.Timchenko,
and
E.E.Medrano
(2009).
SKI knockdown inhibits human melanoma tumor growth in vivo.
|
| |
Pigment Cell Melanoma Res, 22,
761-772.
|
 |
|
|
|
|
 |
I.M.Liu,
S.H.Schilling,
K.A.Knouse,
L.Choy,
R.Derynck,
and
X.F.Wang
(2009).
TGFbeta-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFbeta switch.
|
| |
EMBO J, 28,
88-98.
|
 |
|
|
|
|
 |
J.Baardsnes,
C.S.Hinck,
A.P.Hinck,
and
M.D.O'Connor-McCourt
(2009).
TbetaR-II discriminates the high- and low-affinity TGF-beta isoforms via two hydrogen-bonded ion pairs.
|
| |
Biochemistry, 48,
2146-2155.
|
 |
|
|
|
|
 |
J.N.Cash,
C.A.Rejon,
A.C.McPherron,
D.J.Bernard,
and
T.B.Thompson
(2009).
The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding.
|
| |
EMBO J, 28,
2662-2676.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Nickel,
W.Sebald,
J.C.Groppe,
and
T.D.Mueller
(2009).
Intricacies of BMP receptor assembly.
|
| |
Cytokine Growth Factor Rev, 20,
367-377.
|
 |
|
|
|
|
 |
L.David,
J.J.Feige,
and
S.Bailly
(2009).
Emerging role of bone morphogenetic proteins in angiogenesis.
|
| |
Cytokine Growth Factor Rev, 20,
203-212.
|
 |
|
|
|
|
 |
M.M.Rechtman,
A.Nakaryakov,
K.E.Shapira,
M.Ehrlich,
and
Y.I.Henis
(2009).
Different Domains Regulate Homomeric and Heteromeric Complex Formation among Type I and Type II Transforming Growth Factor-{beta} Receptors.
|
| |
J Biol Chem, 284,
7843-7852.
|
 |
|
|
|
|
 |
M.Tian,
and
W.P.Schiemann
(2009).
Preclinical efficacy of cystatin C to target the oncogenic activity of transforming growth factor Beta in breast cancer.
|
| |
Transl Oncol, 2,
174-183.
|
 |
|
|
|
|
 |
S.Wang,
and
R.Hirschberg
(2009).
Diabetes-relevant regulation of cultured blood outgrowth endothelial cells.
|
| |
Microvasc Res, 78,
174-179.
|
 |
|
|
|
|
 |
A.C.Daly,
R.A.Randall,
and
C.S.Hill
(2008).
Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth.
|
| |
Mol Cell Biol, 28,
6889-6902.
|
 |
|
|
|
|
 |
A.Sorrentino,
N.Thakur,
S.Grimsby,
A.Marcusson,
V.von Bulow,
N.Schuster,
S.Zhang,
C.H.Heldin,
and
M.Landström
(2008).
The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner.
|
| |
Nat Cell Biol, 10,
1199-1207.
|
 |
|
|
|
|
 |
C.Grütter,
T.Wilkinson,
R.Turner,
S.Podichetty,
D.Finch,
M.McCourt,
S.Loning,
L.Jermutus,
and
M.G.Grütter
(2008).
A cytokine-neutralizing antibody as a structural mimetic of 2 receptor interactions.
|
| |
Proc Natl Acad Sci U S A, 105,
20251-20256.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.C.Clarke,
and
X.Liu
(2008).
Decoding the quantitative nature of TGF-beta/Smad signaling.
|
| |
Trends Cell Biol, 18,
430-442.
|
 |
|
|
|
|
 |
J.Massagué
(2008).
A very private TGF-beta receptor embrace.
|
| |
Mol Cell, 29,
149-150.
|
 |
|
|
|
|
 |
R.Stamler,
H.T.Keutmann,
Y.Sidis,
C.Kattamuri,
A.Schneyer,
and
T.B.Thompson
(2008).
The Structure of FSTL3{middle dot}Activin A Complex: DIFFERENTIAL BINDING OF N-TERMINAL DOMAINS INFLUENCES FOLLISTATIN-TYPE ANTAGONIST SPECIFICITY.
|
| |
J Biol Chem, 283,
32831-32838.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Y.Glinka,
and
G.J.Prud'homme
(2008).
Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity.
|
| |
J Leukoc Biol, 84,
302-310.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
| |